FDA commissioner nominee questions do not address dietary supplement issues.
This article was originally published in The Tan Sheet
Executive Summary
PEDIATRIC INDICATIONS, CFC INHALERS AMONG OTC-RELATED ISSUES ADDRESSED in the list of questions forwarded by Senate Labor & Human Resources Committee Chairman James Jeffords (R-Vt.) to FDA Commissioner-nominee Jane Henney, MD, on July 31. The drug issues raised among the list of 140 questions posed in preparation for Henney's confirmation hearing focus almost exclusively on prescription concerns. However, there is overlap with OTCs on some issues, such as pediatric research requirements and the use of chlorofluorocarbons in metered-dose inhalers.